Dr. Shahram Yazdani, MD

Dr. Yazdani practices at Carient Heart & Vascular in Manassas, Virginia.

Dr. Yazdani's NPI, 1174566731, was assigned on June 13, 2006. Dr. Yazdani graduated from New York Medical College in 1991. Dr. Yazdani holds Virginia license 101226688.

Dr. Yazdani's primary practice is Carient Heart & Vascular, at 8100 Ashton Ave, Manassas, VA 20109 in Prince William County. The practice phone is (703) 335-8750.

Dr. Yazdani's primary practice is Carient Heart & Vascular in Manassas, Virginia. Dr. Yazdani is also affiliated with UVA Health Prince William Medical Center. The medical group on file is Carient Heart & Vascular. Dmand AI also links Dr. Yazdani to 4 more hospitals, 1 group practice or clinic and 1 medical group, each named with a free account.

Dmand AI tracks the electronic health record (EHR) system at each site where Dr. Yazdani practices, 6 sites in all. Vendor and product names are available with a free account.

Cardiovascular disease is Dr. Yazdani's primary specialty in the NPI Registry, under taxonomy code 207RC0000X. Dr. Yazdani is board certified in interventional cardiology by the American Board of Internal Medicine. Dr. Yazdani is licensed in Virginia.

CMS data shows 4,289 Medicare services from Dr. Yazdani across 29 procedure codes in 2024, for 1,162 Medicare patients. Medicare paid $622,437 for them.

CMS counts 1,162 Medicare patients who saw Dr. Yazdani in 2024. The largest group is 75 to 84, with 486 patients. 75% of them have high blood pressure, and 75% have high cholesterol. 8% are also on Medicaid. Their average risk score is 1.53, where 1.00 is the Medicare average, so they are sicker than most Medicare patients.

Across all payers, Dmand AI patient panel data puts Dr. Yazdani's median patient age at 74, with 38% women.

In 2024, Dr. Yazdani wrote 2,722 Medicare Part D claims for 449 patients. 82% of them were for generic drugs. CMS names the drug for 2,495 of them, across 35 drugs with 11 or more claims each, at $559,803 in total drug cost. In 2023, CMS named 2,450 claims across 35 drugs.

CMS publishes a Merit-based Incentive Payment System (MIPS) score of 87 out of 100 for Dr. Yazdani for performance year 2024, reported as part of a group. Dr. Yazdani accepts Medicare assignment, so Medicare's approved amount is taken as full payment. CMS lists Dr. Yazdani as offering telehealth. CMS counts 54 procedures of coronary angioplasty and stenting by Dr. Yazdani, more than 86% of the clinicians it reports for that procedure.

Pacemaker insertion or repair: 1 to 10 procedures (CMS shows small counts as a range)

Dmand AI links 9 papers to Dr. Yazdani, published from 2012 to 2021. 2012 was the busiest year, with 2. The most frequent topics are Aortic Valve, Aortic Valve Stenosis and Heart Valve Prosthesis. Dr. Yazdani has published most often in Cardiovasc Revasc Med. Dr. Yazdani's most frequent co-authors are Vasilis C. Babaliaros, MD, Wayne B. Batchelor, MD and Abdulla Al Damluji, MD, MPH.

Dmand AI links Dr. Yazdani to 3 clinical trials. 1 is still active or recruiting. Conditions studied include Heart Failure, Mitral Valve Insufficiency and Ventricular Outflow Obstruction.

CMS Open Payments shows 1,100 general payments to Dr. Yazdani from 51 drug and device companies from 2016 to 2025. Food and beverage make up the largest share, 25% of the total. Cardiovascular Systems Inc. paid the most, $63,181.

Dr. Yazdani graduated from New York Medical College in 1991.